NFKB1 and arthropathy: JQ1, a well-known BET bromodomain inhibitor, plays a crucial role in regulating arthritis inflammation in bone and joint diseases by blocking IKK-dependent activation of NF-κB signaling in rheumatoid arthritis (39).